Citation Tools

Download PDFPDF

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Download to a citation manager

Cite this article as:
Baettig F, Vlajnic T, Vetter M, et al
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response